The long-term objective of this broad-based, multidisciplinary research program in diabetes is to understand the mechanism of noninsulin-dependent diabetes mellitus (NIDDM). This major new effort of East Carolina University is possible because of the availability of: 1) methods for detailed in vitro studies of insulin action and metabolism in human liver, muscle, and adipose tissue; and 2) methods to isolate lipoprotein subfractions and to examine their interactions with macrophages and skin fibroblasts. These technical advances are of maximal value only if they can be applied to a well defined population of patients with and without NIDDM. In the last three years, the Department of Surgery has performed the same gastric bypass procedure in over 300 morbidly obese patients, from whom intraoperative tissue biopsies can be obtained. These patients comprise an interesting population of whom 27% have NIDDM, 20% have impaired glucose tolerance, and the remainder have normal glucose tolerance. Furthermore, over 75% of NIDDM patients are able to maintain euglycemia, following gastric bypass, without drug therapy. Thus, the following objectives can be pursued in this program: 1) To study the mechanism(s) of insulin action at the cellular level in the liver, muscle, and adipose tissue in NIDDM, obese, and nonobese subjects, and to correlate these in vitro data with in vivo assessment of insulin sensitivity; 2) To determine in obese patients the relative distribution of plasma lipoprotein subpopulation and their interaction with macrophages and skin fibroblasts, and correlate these findings with insulin sensitivity as assessed by in vitro and in vivo experimental approaches; 3) To determine the effects of gastric bypass and subsequent predictable weight loss in morbidly obese subjects with and without NIDDM on in vivo and in vitro insulin sensitivity, and determine the effects of glycemic control on lipoprotein metabolism. It is hoped that this work will establish the cellular basis of the pathogenesis of NIDDM and help to develop a more rational therapeutic approach to this major health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK036296-05
Application #
3095411
Study Section
Special Emphasis Panel (ADDK (03))
Project Start
1987-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
East Carolina University
Department
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
Friedman, J E; Caro, J F; Pories, W J et al. (1994) Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism 43:1047-54
Long, S D; O'Brien, K; MacDonald Jr, K G et al. (1994) Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17:372-5
Elton, C W; Tapscott, E B; Pories, W J et al. (1994) Effect of moderate obesity on glucose transport in human muscle. Horm Metab Res 26:181-3
Houmard, J A; Shinebarger, M H; Dolan, P L et al. (1993) Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. Am J Physiol 264:E896-901
Houmard, J A; Hortobagyi, T; Neufer, P D et al. (1993) Training cessation does not alter GLUT-4 protein levels in human skeletal muscle. J Appl Physiol 74:776-81
Spiegelman, D; Israel, R G; Bouchard, C et al. (1992) Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr 55:1033-44
Friedman, J E; Dohm, G L; Leggett-Frazier, N et al. (1992) Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89:701-5
Caro, J F; Jenquin, M; Long, S (1992) Effects of phorbol esters on insulin receptor function and insulin action in hepatocytes: evidence for heterogeneity. Mol Cell Biochem 109:115-8
Contreras, I; Caro, J F; Aveledo, L et al. (1992) In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase. Nephron 61:77-81
Pories, W J; MacDonald Jr, K G; Flickinger, E G et al. (1992) Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 215:633-42;discussion 643

Showing the most recent 10 out of 48 publications